Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines

ME Phillips, AD Hopper, JS Leeds… - BMJ open …, 2021 - bmjopengastro.bmj.com
Introduction Pancreatic exocrine insufficiency is a finding in many conditions, predominantly
affecting those with chronic pancreatitis, pancreatic cancer and acute necrotising …

[HTML][HTML] Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma

J Lv, L Guo, JJ Liu, HP Zhao, J Zhang… - World journal of …, 2019 - ncbi.nlm.nih.gov
The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …

[HTML][HTML] European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, R Barazzoni, L Busetto… - Clinical Nutrition, 2022 - Elsevier
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Systematic review—pancreatic involvement in inflammatory bowel disease

S Massironi, I Fanetti, C Viganò, L Pirola… - Alimentary …, 2022 - Wiley Online Library
Background Inflammatory bowel disease (IBD) is a chronic inflammatory immune‐mediated
disorder of the gut with frequent extra‐intestinal complications. Pancreatic involvement in …

A systematic review of exocrine pancreatic insufficiency prevalence and treatment in type 1 and type 2 diabetes

DM Lewis - Diabetes Technology & Therapeutics, 2023 - liebertpub.com
Type 1 diabetes and type 2 diabetes have high rates of associated exocrine pancreatic
insufficiency (EPI). This review evaluated the current evidence on prevalence and treatment …

European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint European Society for Clinical Nutrition and Metabolism/United European …

SC Bischoff, R Barazzoni, L Busetto… - United European …, 2022 - Wiley Online Library
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Peptide human neutrophil elastase inhibitors from natural sources: an overview

L Marinaccio, A Stefanucci, G Scioli… - International Journal of …, 2022 - mdpi.com
Elastases are a broad group of enzymes involved in the lysis of elastin, the main component
of elastic fibres. They are produced and released in the human body, mainly by neutrophils …

Practical guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, J Ockenga, A Eshraghian, R Barazzoni… - Clinical Nutrition, 2023 - Elsevier
Background Patients with chronic gastrointestinal disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …

Causes of exocrine pancreatic insufficiency other than chronic pancreatitis

L Kunovský, P Dítě, P Jabandžiev, M Eid… - Journal of Clinical …, 2021 - mdpi.com
Exocrine pancreatic insufficiency (EPI), an important cause of maldigestion and malnutrition,
results from primary pancreatic disease or is secondary to impaired exocrine pancreatic …

State of the art in exocrine pancreatic insufficiency

C Diéguez-Castillo, C Jiménez-Luna, J Prados… - Medicina, 2020 - mdpi.com
Exocrine pancreatic insufficiency (EPI) is defined as the maldigestion of foods due to
inadequate pancreatic secretion, which can be caused by alterations in its stimulation …